Trails Edge Capital Partners, LP / IMVT
Trails Edge Capital Partners, LP’s Immunovant Inc Position
Does Trails Edge Capital Partners, LP own Immunovant Inc (IMVT)? Yes — 414.1K shares worth $10M (+2.36% of its 13F portfolio) as of Q1 2026, up from 240.2K shares the prior filed quarter.
Position Value
$10M
Q1 2026
Shares
414.1K
% of Portfolio
+2.36%
Quarters Held
2
currently held
Position History IMVT
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Trails Edge Capital Partners, LP’s full portfolio or all institutional holders of IMVT.